Multilevel barriers to the successful implementation of lung cancer screening: Why does it have to be so hard?

Lisa Carter-Harris, Michael K. Gould

Research output: Contribution to journalReview article

13 Citations (Scopus)

Abstract

The U.S. Preventive Services Task Force recommends lung cancer screening with low-dose computed tomography for long-termcurrent and former smokers. However, lung cancer screening and its implementation are a complex issue. Screening has associated risks and potential harms that complicate the decision to screen for the patient, add to the already time-constrained clinical encounter for the provider, and present logistical and sociopolitical challenges in creating and implementing lung cancer screening programs in the health care system. As lung cancer screening is more widely implemented in the United States, it is critical for those in the health care system to be cognizant of potential barriers to effective screening implementation at the patient, provider, and system levels when designing effective support interventions, as well as to proactively address potential impediments to this new screening option. This paper presents perspectives on these multilevel barriers to lung cancer screening.

Original languageEnglish (US)
Pages (from-to)1261-1265
Number of pages5
JournalAnnals of the American Thoracic Society
Volume14
Issue number8
DOIs
StatePublished - Aug 1 2017

Fingerprint

Early Detection of Cancer
Lung Neoplasms
Delivery of Health Care
Advisory Committees
Tomography

Keywords

  • Implementation
  • Lung cancer screening
  • Multilevel barriers

ASJC Scopus subject areas

  • Medicine(all)
  • Pulmonary and Respiratory Medicine

Cite this

Multilevel barriers to the successful implementation of lung cancer screening : Why does it have to be so hard? / Carter-Harris, Lisa; Gould, Michael K.

In: Annals of the American Thoracic Society, Vol. 14, No. 8, 01.08.2017, p. 1261-1265.

Research output: Contribution to journalReview article

@article{f6dacb0eeb8345a28db2e6a06bc1596d,
title = "Multilevel barriers to the successful implementation of lung cancer screening: Why does it have to be so hard?",
abstract = "The U.S. Preventive Services Task Force recommends lung cancer screening with low-dose computed tomography for long-termcurrent and former smokers. However, lung cancer screening and its implementation are a complex issue. Screening has associated risks and potential harms that complicate the decision to screen for the patient, add to the already time-constrained clinical encounter for the provider, and present logistical and sociopolitical challenges in creating and implementing lung cancer screening programs in the health care system. As lung cancer screening is more widely implemented in the United States, it is critical for those in the health care system to be cognizant of potential barriers to effective screening implementation at the patient, provider, and system levels when designing effective support interventions, as well as to proactively address potential impediments to this new screening option. This paper presents perspectives on these multilevel barriers to lung cancer screening.",
keywords = "Implementation, Lung cancer screening, Multilevel barriers",
author = "Lisa Carter-Harris and Gould, {Michael K.}",
year = "2017",
month = "8",
day = "1",
doi = "10.1513/AnnalsATS.201703-204PS",
language = "English (US)",
volume = "14",
pages = "1261--1265",
journal = "Annals of the American Thoracic Society",
issn = "2325-6621",
publisher = "American Thoracic Society",
number = "8",

}

TY - JOUR

T1 - Multilevel barriers to the successful implementation of lung cancer screening

T2 - Why does it have to be so hard?

AU - Carter-Harris, Lisa

AU - Gould, Michael K.

PY - 2017/8/1

Y1 - 2017/8/1

N2 - The U.S. Preventive Services Task Force recommends lung cancer screening with low-dose computed tomography for long-termcurrent and former smokers. However, lung cancer screening and its implementation are a complex issue. Screening has associated risks and potential harms that complicate the decision to screen for the patient, add to the already time-constrained clinical encounter for the provider, and present logistical and sociopolitical challenges in creating and implementing lung cancer screening programs in the health care system. As lung cancer screening is more widely implemented in the United States, it is critical for those in the health care system to be cognizant of potential barriers to effective screening implementation at the patient, provider, and system levels when designing effective support interventions, as well as to proactively address potential impediments to this new screening option. This paper presents perspectives on these multilevel barriers to lung cancer screening.

AB - The U.S. Preventive Services Task Force recommends lung cancer screening with low-dose computed tomography for long-termcurrent and former smokers. However, lung cancer screening and its implementation are a complex issue. Screening has associated risks and potential harms that complicate the decision to screen for the patient, add to the already time-constrained clinical encounter for the provider, and present logistical and sociopolitical challenges in creating and implementing lung cancer screening programs in the health care system. As lung cancer screening is more widely implemented in the United States, it is critical for those in the health care system to be cognizant of potential barriers to effective screening implementation at the patient, provider, and system levels when designing effective support interventions, as well as to proactively address potential impediments to this new screening option. This paper presents perspectives on these multilevel barriers to lung cancer screening.

KW - Implementation

KW - Lung cancer screening

KW - Multilevel barriers

UR - http://www.scopus.com/inward/record.url?scp=85026756718&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85026756718&partnerID=8YFLogxK

U2 - 10.1513/AnnalsATS.201703-204PS

DO - 10.1513/AnnalsATS.201703-204PS

M3 - Review article

C2 - 28541749

AN - SCOPUS:85026756718

VL - 14

SP - 1261

EP - 1265

JO - Annals of the American Thoracic Society

JF - Annals of the American Thoracic Society

SN - 2325-6621

IS - 8

ER -